Tag Archives: Adults

Older Adults and People with Cancer, Diabetes, HIV/AIDS, Organ Transplants, and Autoimmune Diseases

The food supply in the United States is among the safest in the world. However, when certain disease-causing bacteria or pathogens contaminate food, they can cause foodborne illness, often called “food poisoning.” The Federal government estimates that there are about 48 million cases of foodborne illness annually — the equivalent of sickening 1 in 6… Read More »

Blown up in smoke: Young adults who vape at greater risk of COVID symptoms

COVID-19 has swept across the globe, infecting millions and resulting in hundreds of thousands of deaths. Substantial resources have been invested into understanding individual vulnerability in order to protect those at greatest risk. Age is the most often cited risk factor; 75% of US deaths have been in people over the age of 65, while… Read More »

Is it safe to reduce blood pressure medications for older adults?

“Doctor, can you take away any of my medications? I am taking too many pills.” As physicians, we hear this request frequently. The population most affected by the issue of being prescribed multiple medications, known as polypharmacy, is the elderly. Trying to organize long lists of medications, and remembering to take them exactly as prescribed,… Read More »

Adults With ADHD Three Times As Likely to Develop Dementia

Researchers report that ADHD adults, those adults who are suffering from attention deficit and hyperactivity disorder, are over 3 times as more likely to get a common type of degenerative dementia compared to those not having ADHD.1✅ JOURNAL REFERENCEDOI: 10.1111/j.1468-1331.2010.03064.x The researchers established the association in a study of 360 subjects having degenerative dementia and… Read More »

FDA Approves Rukobia (fostemsavir) for HIV in Adults with Few Treatment Options Available

FDA Approves Rukobia (fostemsavir) for HIV in Adults with Few Treatment Options Available Print this page July 2, 2020 — ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Rukobia (fostemsavir), 600 mg… Read More »